GGrantIndex
← Leaderboards

Marcela F Pasetti

University Of Maryland Baltimore

$26,884,335
Attributed
$28,499,448
Total exposure
14
Grants
14
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $8.3M · FY200625
$10M$7.5M$5M$2.5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$44,536,297 · 15

By mechanism

U19$22,042,586 · 4
R01$19,142,000 · 7
P01$2,927,898 · 3
R21$423,813 · 1

Top collaborators

Most similar at University Of Maryland Baltimore

Same institution · by research overlap

Others in their field

Top investigators on “Immunity

Research focus

ImmunityChildImmune ResponseInfantVaccinesCellsAdultInfectionImmunePreventResponseAntibodiesAntigensLifePathogen5 Year OldMothersVaccine DevelopmentMediatingOrganismShigella InfectionsImmunologicsAffectBase

Grant awards (64)

Maternal Immunization and Determinants of Infant Immunity$3,033,683
U19 · FY2025 · AI · contact PI
Mechanisms of protection against shigellosis in children$1,535,247
R01 · FY2025 · AI · contact PI
O-polysaccharide (OPS)-IpaB Conjugate Vaccine to Prevent Shigellosis$910,903
R01 · FY2025 · AI · contact PI
Maternal Immunization and Determinants of Infant Immunity$788,568
U19 · FY2025 · AI · contact PI
Maternal Immunity$633,717
U19 · FY2025 · AI · contact PI
Broad spectrum Shigella subunit vaccine based on conserved proteins$528,481
R01 · FY2025 · AI · contact PI
Immunology Core$396,676
P01 · FY2025 · AI · contact PI
A quality control pipeline for enhancing reproducibility of immunology studies with shared data$249,800
U19 · FY2025 · AI · contact PI
Maternal Immunization and Determinants of Infant Immunity$249,800
U19 · FY2025 · AI · contact PI
Maternal Immunization and Determinants of Infant Immunity$3,020,031
U19 · FY2024 · AI · contact PI
O-polysaccharide (OPS)-IpaB Conjugate Vaccine to Prevent Shigellosis$884,638
R01 · FY2024 · AI · contact PI
Mechanisms of protection against shigellosis in children$764,815
R01 · FY2024 · AI · contact PI
Maternal Immunity$570,054
U19 · FY2024 · AI · contact PI
Broad spectrum Shigella subunit vaccine based on conserved proteins$526,163
R01 · FY2024 · AI · contact PI
Immunology Core$413,764
P01 · FY2024 · AI · contact PI
Maternal Immunization and Determinants of Infant Immunity$409,114
U19 · FY2024 · AI · contact PI
Maternal Immunization and Determinants of Infant Immunity, A FAIR, portable, cloud-based immunology data management and discovery platform$311,470
U19 · FY2024 · AI · contact PI
Maternal Immunization and Determinants of Infant Immunity$3,111,452
U19 · FY2023 · AI · contact PI
Maternal Immunity$986,751
U19 · FY2023 · AI · contact PI
O-polysaccharide (OPS)-IpaB Conjugate Vaccine to Prevent Shigellosis$898,263
R01 · FY2023 · AI · contact PI
Mechanisms of protection against shigellosis in children$764,815
R01 · FY2023 · AI · contact PI
Broad spectrum Shigella subunit vaccine based on conserved proteins$531,262
R01 · FY2023 · AI · contact PI
Maternal Immunization and Determinants of Infant Immunity$520,041
U19 · FY2023 · AI · contact PI
Immunology Core$417,439
P01 · FY2023 · AI · contact PI
Maternal Immunization and Determinants of Infant Immunity$3,121,843
U19 · FY2022 · AI · contact PI
Mechanisms of protection against shigellosis in children$778,440
R01 · FY2022 · AI · contact PI
Maternal Immunity$581,515
U19 · FY2022 · AI · contact PI
Broad spectrum Shigella subunit vaccine based on conserved proteins$523,290
R01 · FY2022 · AI · contact PI
Maternal Immunization and Determinants of Infant Immunity$383,406
U19 · FY2022 · AI · contact PI
Immunology Core$340,026
P01 · FY2022 · AI · contact PI
Maternal Immunization and Determinants of Infant Immunity$3,188,570
U19 · FY2021 · AI · contact PI
Broad spectrum Shigella subunit vaccine based on conserved proteins$536,410
R01 · FY2021 · AI · contact PI
Maternal Immunity$522,202
U19 · FY2021 · AI · contact PI
Immunology Core$409,371
P01 · FY2021 · AI · contact PI
Maternal Immunization and Determinants of Infant Immunity$360,569
U19 · FY2021 · AI · contact PI
Serological assays to predict Shigella vaccine efficacy$542,758
R01 · FY2020 · AI · contact PI
Immunology Core - Pasetti$196,787
P01 · FY2020 · AI · contact PI
Serological assays to predict Shigella vaccine efficacy$570,568
R01 · FY2019 · AI · contact PI
Vaccines and maternally acquired immunity to prevent shigellosis in children$467,512
R01 · FY2019 · AI · contact PI
Immunology Core - Pasetti$207,286
P01 · FY2019 · AI · contact PI
Serological assays to predict Shigella vaccine efficacy$573,658
R01 · FY2018 · AI · contact PI
Vaccines and maternally acquired immunity to prevent shigellosis in children$380,219
R01 · FY2018 · AI · contact PI
Immunology Core - Pasetti$196,787
P01 · FY2018 · AI · contact PI
Vaccines and maternally acquired immunity to prevent shigellosis in children$36,629
R01 · FY2018 · AI · contact PI
Serological assays to predict Shigella vaccine efficacy$570,415
R01 · FY2017 · AI · contact PI
Vaccines and maternally acquired immunity to prevent shigellosis in children$397,198
R01 · FY2017 · AI · contact PI
Immunology Core - Pasetti$196,787
P01 · FY2017 · AI · contact PI
Role of maternal and infant vaccine-induced IgG in protection against pertussis$192,813
R21 · FY2017 · AI · contact PI
Serological assays to predict Shigella vaccine efficacy$585,428
R01 · FY2016 · AI · contact PI
Vaccines and maternally acquired immunity to prevent shigellosis in children$380,219
R01 · FY2016 · AI · contact PI
Role of maternal and infant vaccine-induced IgG in protection against pertussis$231,000
R21 · FY2016 · AI · contact PI
Immunology Core - Pasetti$152,975
P01 · FY2016 · AI · contact PI
Vaccines and maternally acquired immunity to prevent shigellosis in children$375,939
R01 · FY2015 · AI · contact PI
A. L. lactis-based vaccine for children with broad spectrum for enteric pathogens$640,986
R01 · FY2014 · AI · contact PI
A. L. lactis-based vaccine for children with broad spectrum for enteric pathogens$607,356
R01 · FY2013 · AI · contact PI
A. L. lactis-based vaccine for children with broad spectrum for enteric pathogens$648,884
R01 · FY2012 · AI · contact PI
A. L. lactis-based vaccine for children with broad spectrum for enteric pathogens$649,142
R01 · FY2011 · AI · contact PI
A. L. lactis-based vaccine for children with broad spectrum for enteric pathogens$683,858
R01 · FY2010 · AI · contact PI
Immune Responses to Biodefense Vaccines Early in Life$315,089
R01 · FY2010 · AI · contact PI
Immune Responses to Biodefense Vaccines Early in Life$47,775
R01 · FY2010 · AI · contact PI
Immune Responses to Biodefense Vaccines Early in Life$437,396
R01 · FY2009 · AI · contact PI
Immune Responses to Biodefense Vaccines Early in Life$353,635
R01 · FY2008 · AI · contact PI
Immune Responses to Biodefense Vaccines Early in Life$360,484
R01 · FY2007 · AI · contact PI
Immune Responses to Biodefense Vaccines Early in Life$334,125
R01 · FY2006 · AI · contact PI